Quidel Stock Forecast, Price & News

Quidel's stock was trading at $89.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, QDEL shares have increased by 105.4% and is now trading at $184.21.
View which stocks have been most impacted by COVID-19.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Quidel.

Quidel is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Quidel.

Quidel Co. (NASDAQ:QDEL) posted its earnings results on Thursday, July, 30th. The company reported $1.77 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.12 by $0.65. The business earned $201.75 million during the quarter, compared to analysts' expectations of $201.40 million. Quidel had a return on equity of 33.86% and a net margin of 23.61%.
View Quidel's earnings history.

Quidel issued an update on its second quarter 2020 After-Hours earnings guidance on Monday, July, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $201-202 million, compared to the consensus revenue estimate of $178.91 million.

6 equities research analysts have issued twelve-month price objectives for Quidel's shares. Their forecasts range from $75.00 to $363.00. On average, they expect Quidel's stock price to reach $189.67 in the next twelve months. This suggests a possible upside of 3.0% from the stock's current price.
View analysts' price targets for Quidel.

Quidel saw a increase in short interest in August. As of August 31st, there was short interest totaling 2,070,000 shares, an increase of 13.1% from the August 15th total of 1,830,000 shares. Based on an average trading volume of 1,400,000 shares, the short-interest ratio is currently 1.5 days. Currently, 5.6% of the shares of the stock are short sold.
View Quidel's Short Interest.

Some companies that are related to Quidel include Align Technology (ALGN), West Pharmaceutical Services (WST), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Cerus (CERS), OraSure Technologies (OSUR), Meridian Bioscience (VIVO), Anika Therapeutics (ANIK) and Antares Pharma (ATRS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Quidel investors own include NVIDIA (NVDA), Shopify (SHOP), Docusign (DOCU), Paypal (PYPL), Square (SQ), Netflix (NFLX), Tesla (TSLA), salesforce.com (CRM), Okta (OKTA) and Teladoc Health (TDOC).

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

Quidel's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.53%), FMR LLC (6.90%), ArrowMark Colorado Holdings LLC (2.04%), William Blair Investment Management LLC (1.30%), Cannell Peter B & Co. Inc. (1.25%) and New York State Common Retirement Fund (1.08%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Edward L Michael, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Matthew Strobeck, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll.
View institutional ownership trends for Quidel.

QDEL stock was sold by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., New York State Common Retirement Fund, Vanguard Group Inc., BNP PARIBAS ASSET MANAGEMENT Holding S.A., Gabelli Funds LLC, Sei Investments Co., Public Employees Retirement Association of Colorado, and Gamco Investors INC. ET AL. Company insiders that have sold Quidel company stock in the last year include Edward Keith Russell, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, and Werner Kroll.
View insider buying and selling activity for Quidel.

QDEL stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, William Blair Investment Management LLC, Cannell Peter B & Co. Inc., Bank of New York Mellon Corp, Prudential Financial Inc., Principal Financial Group Inc., Principal Financial Group Inc., and Stephens Investment Management Group LLC. Company insiders that have bought Quidel stock in the last two years include Douglas C Bryant, Edward L Michael, and Matthew Strobeck.
View insider buying and selling activity for Quidel.

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of QDEL stock can currently be purchased for approximately $184.21.

Quidel has a market capitalization of $7.73 billion and generates $534.89 million in revenue each year. The company earns $72.92 million in net income (profit) each year or $2.73 on an earnings per share basis. Quidel employs 1,250 workers across the globe.

The official website for Quidel is www.quidel.com.

Quidel's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The company can be reached via phone at 858-552-1100 or via email at [email protected]